AdaptHealth Projects FY26 Revenue Between $3.45B and $3.52B
AHCO sits 57% above its 52-week low of $7.95.
Summary
AdaptHealth Corp. has issued its financial guidance for fiscal year 2026, forecasting revenue to be in the range of $3.45 billion to $3.52 billion. This new guidance provides a forward-looking outlook for the company's performance, following its recent 10-K filing which reported a net loss for 2025. This revenue projection is a critical piece of information for investors and analysts to update their financial models and assess the company's future growth trajectory and valuation. Traders will now compare this guidance against existing consensus estimates to determine potential market reaction and will monitor future earnings reports for any updates or changes to these projections.
At the time of this announcement, AHCO was trading at $12.51 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $7.95 to $13.43. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.